Cochrane · systematic review · CD010406

Corticosteroids as adjunctive therapy in the treatment of influenza

Lansbury, L, Rodrigo, C, Leonardi‐Bee, J, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

Acute Respiratory Infections2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 4 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Corticosteroid therapy compared to no corticosteroid therapy in the treatment of influenza

Population: individuals with influenza
4 questions
OutcomeEffectEvidenceStatus / GRADE
Number of deaths at 30 days following admission (30‐day mortality)a
Corticosteroid therapy vs no corticosteroid therapy
OR 3.9 [2.31, 6.6]21 studies · 9536 participantsVery low
Downgraded: risk of bias, inconsistency
Rate of admission to intensive care units
Corticosteroid therapy vs no corticosteroid therapy
OR 5.13 [4.26, 6.17]1 study · 2141 participantsVery low
Downgraded: risk of bias
Number and nature of adverse events secondary to corticosteroid use (hospital‐acquired infection)
Corticosteroid therapy vs no corticosteroid therapy
OR 2.74 [1.51, 4.95]7 studies · 6114 participantsVery low
Downgraded: risk of bias, inconsistency
Proportion of participants requiring mechanical ventilation
Corticosteroid therapy vs no corticosteroid therapy
no estimate extracted4 studies · 4364 participantsVery low
Downgraded: risk of bias, inconsistency